On Tuesday, Congressional leaders spent two hours taking to task Novo Nordisk CEO Lars Fruergaard Jørgensen over the high ...

Patients taking Ozempic were about 60% less likely to have an opioid overdose compared to those taking other diabetes drugs.

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...

WASHINGTON—U.S. Senator Mike Braun questioned Novo Nordisk CEO, Lars Fruergaard Jørgensen, at the Senate Health, Education, ...

The results of Novo Nordisk’s phase 1 trials shows the oral weight loss pill could be more effective than semaglutide.

Sanders found unlikely common ground with pro-Trump Elon Musk, citing the tech mogul as “right” on “solving obesity” in a ...

People with a history of opioid abuse who took Novo Nordisk A/S’s Ozempic were less likely to overdose, according to a study ...

Sen. Bernie Sanders pressed the Novo Nordisk CEO about why the company charges Americans far more than other countries for the same drug.

Novo Nordisk said it’s open to discussions with PBMs based on their commitments that a lower semgalutide list price would not ...

On Capitol Hill lawmakers grilled the CEO of the company that makes popular weight loss drugs Ozempic and Wegovy.

Novo Nordisk has a price fix solution for uninsured patients with diabetes, but not for HSA holders or people with normal ...

U.S. Sen. Bernie Sanders said major PBMs have agreed not to limit coverage of Ozempic and Wegovy if Novo lowers its prices.